v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net loss $ (12,752) $ (10,504)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 36 83
Amortization of right-of-use assets 126 121
Unrealized loss on investment 1 0
Share-based compensation expense 184 254
Changes in operating assets and liabilities:    
Trade and other receivables 0 (50)
Prepaid and other assets 846 388
Trade and other payables 1,707 (50)
Accrued employee benefits 46 (5)
Lease liabilities (136) (125)
Net cash used in operating activities (9,942) (9,888)
Cash flows from investing activities:    
Net cash used in investing activities 0 0
Cash flows from financing activities:    
Proceeds from issuance and exercise of common stock, pre-funded warrants, and common warrants 30,922 17,884
Shares and pre-funded warrant issuance costs (2,964) (1,869)
Net cash provided by financing activities 27,958 16,015
Effects of exchange rate changes on cash, cash equivalents, and restricted cash (118) 348
Net increase in cash, cash equivalents, and restricted cash 17,898 6,475
Cash, cash equivalents, and restricted cash, beginning of period 2,490 4,076
Cash, cash equivalents, and restricted cash, end of period $ 20,388 $ 10,551

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL